Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Centrum ads perform

This article was originally published in The Tan Sheet

Executive Summary

FSI drop June 9 offers $1-off coupon on any Centrum Performance Energy Bar. Promotions include taglines "energy bars should help you burn rubber...not taste like it" and "finally, an energy nutrition bar that tastes as great as it performs." Wyeth Consumer Healthcare will also promote product with summer-long campaign touring concerts, sporting events "to engage and energize active, on-the-go consumers." Upcoming events are in L.A., New York, San Francisco, feature promotional offers and local sweepstakes. Free offers also are available at 1Centrum Web site. Bars offer 21 vitamins and minerals, mark Wyeth's functional food debut (2"The Tan Sheet" May 6, 2002, p. 9)...

You may also be interested in...



Centrum Performance Energy Nutrition Bars: Wyeth’s Functional Food Debut

Wyeth Consumer Healthcare is looking to build on the success of its Centrum franchise with the launch of Centrum Performance energy nutrition bars, the firm's first functional food

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel